GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Anteris Technologies Global Corp (ASX:AVR) » Definitions » Equity-to-Asset

Anteris Technologies Global (ASX:AVR) Equity-to-Asset : 0.78 (As of Dec. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Anteris Technologies Global Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Anteris Technologies Global's Total Stockholders Equity for the quarter that ended in Dec. 2024 was A$99.10 Mil. Anteris Technologies Global's Total Assets for the quarter that ended in Dec. 2024 was A$127.42 Mil. Therefore, Anteris Technologies Global's Equity to Asset Ratio for the quarter that ended in Dec. 2024 was 0.78.

The historical rank and industry rank for Anteris Technologies Global's Equity-to-Asset or its related term are showing as below:

ASX:AVR' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.19   Med: 0.63   Max: 0.88
Current: 0.78

During the past 13 years, the highest Equity to Asset Ratio of Anteris Technologies Global was 0.88. The lowest was 0.19. And the median was 0.63.

ASX:AVR's Equity-to-Asset is ranked better than
71.08% of 868 companies
in the Medical Devices & Instruments industry
Industry Median: 0.63 vs ASX:AVR: 0.78

Anteris Technologies Global Equity-to-Asset Historical Data

The historical data trend for Anteris Technologies Global's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anteris Technologies Global Equity-to-Asset Chart

Anteris Technologies Global Annual Data
Trend Jun15 Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.19 0.49 0.56 0.63 0.78

Anteris Technologies Global Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 0.62 0.63 0.21 0.78

Competitive Comparison of Anteris Technologies Global's Equity-to-Asset

For the Medical Devices subindustry, Anteris Technologies Global's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anteris Technologies Global's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Anteris Technologies Global's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Anteris Technologies Global's Equity-to-Asset falls into.


;
;

Anteris Technologies Global Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Anteris Technologies Global's Equity to Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Equity to Asset (A: Dec. 2024 )=Total Stockholders Equity/Total Assets
=99.1/127.424
=0.78

Anteris Technologies Global's Equity to Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

Equity to Asset (Q: Dec. 2024 )=Total Stockholders Equity/Total Assets
=99.1/127.424
=0.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anteris Technologies Global  (ASX:AVR) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Anteris Technologies Global Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Anteris Technologies Global's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Anteris Technologies Global Business Description

Traded in Other Exchanges
N/A
Address
9 Sherwood Road, Level 3, Suite 302, Toowong, QLD, AUS, 4066
Anteris Technologies Global Corp is a structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Its product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with the world's interventional cardiologists and cardiac surgeons to treat aortic stenosis a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow. Company operates in USA, Germany, Australia, Switzerland, and Sweden. Majority of revenue is from USA.